As of 2024-12-04, the Relative Valuation of PTC Therapeutics Inc (PTCT) is (124.04) USD. This relative valuation is based on P/E multiples. With the latest stock price at 43.88 USD, the upside of PTC Therapeutics Inc based on Relative Valuation is -382.7%.
The range of the Relative Valuation is (123.10) - (135.79) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.2x - 23.0x | 19.4x |
| Forward P/E multiples | 19.8x - 21.8x | 20.5x |
| Fair Price | (123.10) - (135.79) | (124.04) |
| Upside | -380.5% - -409.5% | -382.7% |
| Date | P/E |
| 2024-12-03 | -8.09 |
| 2024-12-02 | -8.37 |
| 2024-11-29 | -7.06 |
| 2024-11-27 | -7.26 |
| 2024-11-26 | -7.40 |
| 2024-11-25 | -6.91 |
| 2024-11-22 | -6.95 |
| 2024-11-21 | -6.90 |
| 2024-11-20 | -6.75 |
| 2024-11-19 | -6.33 |
| 2024-11-18 | -6.31 |
| 2024-11-15 | -6.31 |
| 2024-11-14 | -6.82 |
| 2024-11-13 | -7.08 |
| 2024-11-12 | -7.18 |
| 2024-11-11 | -7.22 |
| 2024-11-08 | -7.12 |
| 2024-11-07 | -6.91 |
| 2024-11-06 | -6.95 |
| 2024-11-05 | -6.57 |
| 2024-11-04 | -6.50 |
| 2024-11-01 | -6.51 |
| 2024-10-31 | -6.42 |
| 2024-10-30 | -6.54 |
| 2024-10-29 | -6.84 |
| 2024-10-28 | -6.51 |
| 2024-10-25 | -6.55 |
| 2024-10-24 | -6.66 |
| 2024-10-23 | -6.83 |
| 2024-10-22 | -6.32 |
| 2024-10-21 | -6.18 |
| 2024-10-18 | -6.29 |
| 2024-10-17 | -5.95 |
| 2024-10-16 | -5.90 |
| 2024-10-15 | -6.04 |
| 2024-10-14 | -6.30 |
| 2024-10-11 | -6.27 |
| 2024-10-10 | -6.19 |
| 2024-10-09 | -6.42 |
| 2024-10-08 | -6.56 |
| 2024-10-07 | -5.63 |
| 2024-10-04 | -5.65 |
| 2024-10-03 | -5.69 |
| 2024-10-02 | -5.86 |
| 2024-10-01 | -5.80 |
| 2024-09-30 | -5.97 |
| 2024-09-27 | -6.04 |
| 2024-09-26 | -6.06 |
| 2024-09-25 | -5.89 |
| 2024-09-24 | -5.87 |